Archives
(S)-(+)-Methoprene and Locust JH Control
2026-11-18
Li and colleagues connect stage-dependent microRNA repression with juvenile hormone biosynthesis, vitellogenin production, and ovarian development in migratory locusts. The study’s methoprene perturbation supports a pathway-level role for juvenile hormone in reproduction, while the molecular data provide the stronger evidence for coordinated miRNA–mRNA regulation.
A Milk-Protein Locus for Rabbit Pharming
2026-11-18
A 2025 study tested whether placing a recombinant reporter gene at the rabbit CSN2 milk-protein locus could overcome the variable expression associated with conventional transgenic animal production. The reported milk concentrations were substantially higher than historical rabbit pharming yields, but the evidence remains a proof of concept because it is based on a reporter protein and a small number of homozygous animals.
How CSN2 Targeting Raised Rabbit Milk Yields
2026-11-17
A 2025 study used targeted insertion at the rabbit CSN2 locus to place a reporter gene under the control of an endogenous milk-protein promoter. The resulting line produced 15–20 g/L of tdTomato in milk, but the evidence remains a proof of concept rather than a validation of therapeutic-protein manufacturing.
What High-Yield Rabbit Pharming Evidence Shows
2026-11-17
A recent rabbit study reports markedly higher milk concentrations of a fluorescent recombinant protein after targeted insertion at the endogenous CSN2 locus. The result supports a strong locus-and-promoter hypothesis, but its generalizability to therapeutic proteins, animal-wide productivity, and manufacturing performance remains unresolved.
Why the CSN2 Locus Raises Rabbit Milk Protein Yield
2026-11-16
A mechanistic analysis of targeted expression at the rabbit CSN2 locus, the evidence behind reported tdTomato yields of 15–20 g/L, and the limits of comparison with conventional pharming lines.
Why CSN2 Targeting Raised Rabbit Pharming Yield
2026-11-16
A 2025 study tested whether placing a reporter transgene at the endogenous rabbit CSN2 milk-protein locus could improve expression in milk. Its reported 15–20 g/L output in two homozygous females is notable, but the result remains a proof of concept because the protein was tdTomato, the high-yield cohort was small, and historical comparisons were not matched head-to-head.
Dual-Target CAR-T: Mechanism and Measurement
2026-11-15
A source-grounded interpretation of how simultaneous CD276 and NKG2D-ligand recognition may reduce antigen-escape failure in non-small cell lung cancer, and how chemiluminescent protein detection supports—but does not establish—the mechanistic conclusions.
H-89 in Wnt–O-GlcNAc Bone Signaling
2026-11-14
A mechanistic interpretation of how H-89 can interrogate the PKA-linked branch of Wnt-driven O-GlcNAcylation, glycolysis, and osteogenesis, while distinguishing pharmacological evidence from stronger genetic and metabolic findings.
What High-Yield Rabbit Pharming Evidence Shows
2026-11-13
A primary rabbit study reports 15–20 g/L tdTomato in milk from two homozygous females after targeted insertion at the endogenous CSN2 locus. The finding supports a locus- and promoter-based explanation for higher expression, but historical controls, the small biological sample, reporter choice, and unmeasured product-quality endpoints limit claims about general pharming performance.
What High-Yield Rabbit Pharming Evidence Shows
2026-11-13
A published rabbit study links targeted expression at the endogenous CSN2 locus with markedly higher reporter-protein concentrations in milk. The result is promising, but cross-study comparisons, a small directly observed animal set, and the use of tdTomato leave important questions about reproducibility, protein-specific performance, and translational relevance.
Why CSN2 Targeting Raises Rabbit Milk Yield
2026-11-12
A 2025 study links targeted expression at the endogenous CSN2 milk-protein locus with markedly higher reporter-protein concentrations in rabbit milk. The evidence supports a promoter-and-locus mechanism, but its generality is limited by the reporter model, small number of high-yield animals, and lack of a matched head-to-head comparison.
What the CSN2 Rabbit Pharming Study Shows
2026-11-12
A 2025 study reported unusually high tdTomato abundance in milk from homozygous CSN2 knock-in rabbits. The result supports locus-directed expression as a promising hypothesis for animal pharming, while leaving important questions about protein-specific performance, reproducibility, comparability, and translation unresolved.
Why CSN2 Targeting Raises Rabbit Milk Yield
2026-11-11
A mechanistic editorial examining how targeted integration at the rabbit CSN2 locus may improve recombinant-protein production, what the reported tdTomato yields establish, and where the evidence remains limited.
Why the CSN2 Locus Matters in Rabbit Pharming
2026-11-11
A literature-focused analysis of a CRISPR/Cas9 rabbit line that used the endogenous CSN2 milk-protein locus to drive tdTomato expression, reaching 15–20 g/L in milk from two homozygous females while leaving important questions about therapeutic generalizability and product quality.
CSN2 Targeting and High-Yield Rabbit Pharming
2026-11-10
A locus-directed strategy placed a reporter transgene under the control of the endogenous rabbit CSN2 milk-protein regulatory context. The reported 15–20 g/L milk concentration is a strong proof of concept for genomic-context effects, but it does not by itself establish therapeutic protein quality, process yield, or general performance across transgenes.